Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Botelho

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Life Science Alliance|May 2, 2022
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transitionMargarida C Quaresma, Hugo M Botelho, Ines Pankonien, et al.
Journal of Molecular Biology|January 6, 2022
Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic FibrosisMadalena C Pinto, Hugo M Botelho, Iris A L Silva, et al.
Cells|April 25, 2019
Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic ReticulumJoão D Santos, Sara Canato, Ana S Carvalho, et al.
International Journal of Molecular Sciences|July 9, 2022
Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell NucleusCélia Fernandes, Elisa Palma, Francisco Silva, et al.
Bioinformatics (Oxford, England)|December 28, 2020
An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assayMarne C Hagemeijer, Annelotte M Vonk, Nikhil T Awatade, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2018
R560S: A class II CFTR mutation that is not rescued by current modulatorsNikhil T Awatade, Sofia Ramalho, Iris A L Silva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 21, 2017
A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 trafficJoana R Lérias, Madalena C Pinto, Hugo M Botelho, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
Biochemical and biophysical characterization of recombinant yeast proteasome maturation factor ump1Bebiana Sá-Moura, Ana Marisa Simões, Joana Fraga, et al.
Science Advances|July 3, 2018
The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregationJoana S Cristóvão, Vanessa K Morris, Isabel Cardoso, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 31, 2020
Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>GIris A L Silva, Tereza Doušová, Sofia Ramalho, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Life Science Alliance|May 2, 2022
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transitionMargarida C Quaresma, Hugo M Botelho, Ines Pankonien, et al.
Journal of Molecular Biology|January 6, 2022
Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic FibrosisMadalena C Pinto, Hugo M Botelho, Iris A L Silva, et al.
Cells|April 25, 2019
Folding Status Is Determinant over Traffic-Competence in Defining CFTR Interactors in the Endoplasmic ReticulumJoão D Santos, Sara Canato, Ana S Carvalho, et al.
International Journal of Molecular Sciences|July 9, 2022
Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell NucleusCélia Fernandes, Elisa Palma, Francisco Silva, et al.
Bioinformatics (Oxford, England)|December 28, 2020
An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assayMarne C Hagemeijer, Annelotte M Vonk, Nikhil T Awatade, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2018
R560S: A class II CFTR mutation that is not rescued by current modulatorsNikhil T Awatade, Sofia Ramalho, Iris A L Silva, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|November 21, 2017
A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 trafficJoana R Lérias, Madalena C Pinto, Hugo M Botelho, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
Biochemical and biophysical characterization of recombinant yeast proteasome maturation factor ump1Bebiana Sá-Moura, Ana Marisa Simões, Joana Fraga, et al.
Science Advances|July 3, 2018
The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregationJoana S Cristóvão, Vanessa K Morris, Isabel Cardoso, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 31, 2020
Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>GIris A L Silva, Tereza Doušová, Sofia Ramalho, et al.
Pageof 4